Captiva Verde Land Corp. (CNSX:PWR) entered into an exchange agreement Salud Esmeralda de Mexico SA de CV from Jeff Ciachurski and others for CAD 20 million on October 2, 2019. Under the terms, Salud Esmeralda will receive 80 million common shares of Captiva. The shares are subject to a pooling agreement for one year. The transaction is subject to approval from Canadian Securities Exchange. On July 27, 2020, Captiva Verde executed the agreement and Captiva Verde is 75% complete in constructing its brand new drug manufacturing facility in Mexico for preparation of manufacturing and sales to the Union Federation in November 2020. The Share Exchange Agreement and its resolutions are currently waiting for the filing of a signature verification process from the Mexican Consulate in Vancouver. Final approval is then subject to the Canadian Securities Exchange once the Mexican Consulate has verified the Canadian resolutions including the corporate documents of Captiva Verde.

Captiva Verde Land Corp. (CNSX:PWR) cancelled the acquisition of Salud Esmeralda de Mexico SA de CV from Jeff Ciachurski and others on October 31, 2022. The Company determined that they would no longer pursue the Esmeralda transaction and has written off the receivable and property, plant and equipment. The receivable had no repayment terms, was non-secured and non-interest bearing.